homozygous twins genetic, immunosuppressive regimens can theo-reticccally be avoided.
However, any individual who receives a new kidney has a high risk of the initial kidney disease returning just as much as new-onset nephropathy. Furthermore, immunosuppressive regimens can treat both pathological conditions [8, 9] .In fact, two of the first twins transplanted by Murray develop glomerulonephritis and eventually died because of this.
At the beginning, it was thought that bilateral native nephrectomy would reduce the risk of recurrence but with time shown that this was not the case. Later on, azathioprine and steroids were introduced to overcome the problem of recurrence but not all transplant units found this necessary [8, 9] .
From this case, the use of immunosuppressive regimens when the donor and the recipient of the kidney transplant are identical twins must be considered. [10] Here we present the first case of kidney transplantation of identical twins in our center, including the operation technique, therapeutic regimens and patient outcome during hospitalization follow-up.
CASE PRESENTATION
A 42-year-old Melanesia male with a history of ESRD (End Stage of Renal Disease) secondary to hypertension received a living related renal transplant from his HLA identical twin brother. Prior to transplantation, he had been on hemodialysis for 13 months.
Monozygosity was not analyzed by DNA techniques, zygosity was being assumed from HLA typing. Additionally, he was found to be 16 matches on HLA typing and had a negative anti-human globulin (AHG) crossmatch.
The healthy potential donor (identical twin brother) has evidence of normal renal function bilaterally, free from infection, have a normal lower urinary tract and has sufficient understanding of the significance of a unilateral nephrectomy.
Operative Technique
The operation consists of two simultaneous operations in two adjacent operating rooms, the nephrectomy and the transplantation.
The nephrectomy of left kidney on a healthy donor requires careful dissection of the vasculature to obtain maximum length of the renal artery and vein (Figure 1. ).
Figure1. Clamping of renal blood supply from the donor
After the kidney taken from the donor, the kidney was diluted with normal saline solution in a cold storage (Fig2.).
The recipient site is prepared in the right lower quadrant retroperitoneally exposing the iliac vessels from the bifurcation of the aorta to the inguinal ligament. The retroperitoneal area is dissected widely in a lateral direction to allow room for the kidney.
The renal artery is anatomosed end-to-side to the external iliac artery and the renal vein endto-side to the external iliac vein (Figure 3 .). The ureter is passed through a muscular tunnel and sutured to the bladder mucosa. 
Warm and Cold Ischemia Time
The time lapse from clamping of blood supply in the donor to its restoration in the recipient has been 44min23s that known as total ischemic time.
The total ischemic time divided into warm and cold ischemic times, with the warm ischemic time (WIT) I and II were 13m28s and 22m16s, respectively. The cold ischemia time (CIT) was 8min39s. Urine flow starts immediately after 9 seconds after transplantation.
Therapeutic Regimen
The donor received a 3-day course of steroids, consisting of methyl-prednisolone 500 mg intraoperatively, followed by 250 mg and 125 mg on postoperative days (POD) 1&2, respectively. He also received maintenance immunosuppression of tacrolimus 0.2 mg / kg per day every 8 hours orally, basiliximab 20 mg daily intravenously and mycophenolic acid 1g every 12hours intravenously.
Opportunistic infection prophylaxis was also provided such as fungal prophylaxis with oral cotrimoxazole 10 mg three times daily and valganciclovir 450 -mg daily for cytomegalovirus (CMV) prophylaxis.
Post-Operative Course
The donor is living and well without disability. On abdominal ultrasound (Fig6.) post-operative day (POD) 1 showed that renal size was normal, no pelvicalyceal system dilatation, no perirenal fluid collection was observed.
In color doppler ultrasound showed that the blood flow distributed till the peripheral of the renalparenchym. 
Figure4. Serum creatinine trend after transplantation

DISCUSSION
Living donor transplantation offers better renal survival, better quality of life, and cost-effective treatment [12] many studies have shown that renal transplant among monozygotic twins is the best treatment option with excellent renal and overall survival.
Low risk of allograft rejection but there is disagreement regarding the immunosuppressive therapy they should receive. 13
Kessaris et al. showed that in the United Kingdon more than 50% and the in the USA more than two-third of patients with a renal transplant from their identical twin were receiving long-term immunosuppressive therapy14
Where as in review by Krishnan In the survival analysis the group that stopped immunosuppression had better renal survival at 1 year.13
This was the first kidney transplantation in twin that performed in our health center. A 42-yearoldmale with a history of ESRD (End Stage of Renal Disease) secondary to hypertension received a living related renal transplant from his HLA identical twin brother.
The patient received methylprednisolone 500 mg intraoperatively, followed by 250 mg and 125 mg on postoperative days (POD) 1 and 2, respectively. The aim of steroid therapy is to preventing ischaemia-reperfusion damage.
Damage from ischaemia reperfusion during surgery activates cytokines that can activate the immune response despite complete HLA identity between the donor and recipient.
It has also been described that ischaemia can modify donor DNA and genetic expression posttransplant. [15] Therefore; we suggest the use of immunosuppressive therapy to block the immune response at several levels and reduce the risk of acute rejection. The patient has no evidence of acute allograft rejection along the hospitalization, also no infectious complications from short-term immunosuppression.
There were not much different in operation technique of kidney transplant in this patient compared to common kidney transplantation.
The donor has underwent several screenings to prove the evidence of normal renal function, infection free, normal lower urinary tract and has sufficient understanding of the significance of a unilateral nephrectomy.
In procedural time, the recipient warm ischemic time II was 22min16s which shorter than mean of warm ischemic time II (27.9min) in kidney transplants in national level.
The length of stay of this recipient (12 days) was in the range of average length of stay in overall kidney transplant in Indonesia.15
Renal allograft dysfunction is common complication post transplantation and can lead to a graft dysfunction.
Creatinine, a product of muscle breakdown, is widely used as a marker of renal function as it is excreted in the glomerulus and to a lesser extent the proximal tubule. In this study showed that the average serum creatinine post-operative in recipient was 2,76 mg/dL. Range from 10.32 mg/dL (POD 0) gradually decline to 1.1 mg/dL in 12 days (Figure 4 .).
Hariharan et al. reported that the improved halflife in recent years was seen predominantly in those patients with one-year creatinine value <1.5 mg/dL.
In the setting acute rejection, the preservation of renal function that is more important for graft survival. [11, 13] This study also provides urine output measurement as early clinical parameters, that collected on a routine basis to monitor graft function immediately after transplantation to provide an insight into the long-term function of the graft. Other studies have indicated that the magnitude of urine output is one of the most clinically used predictors for graft function immediately after reperfusion.14 We evaluated the urine output from the POD 0 till patient discharged (Fig5). The diuresis reached 8.3 cc/ kg BW / hour for the first 24 hours, and gradually tapered off to normal ranges.
It is important to monitor the urine output after the transplant to evaluate the graft function.
As over infusion can lead to tissue edema with decreased tissue oxygenation and subjects vulnerable to suffer pulmonary edema, infections, myocardial ischemia, ileus, compromised renal flow, renal injury and even increased mortality [12] .
Permanent function of a transplanted vascularized organ is possible between monozygotic (identical) twins by virtue of a genetic constitution which is identical gene for gene.
By contrast, transplantation between all other human being has failed after a variable period pf function, presumably because of an antibody response of the recipient developing against the nuclear antigen of the donor.11,14
CONCLUSION
This is the first case report of kidney transplantation in identical twins in our health center. As considering of acute graft rejection possibility, patient received immunosuppressant regiment, which has shown a good outcome of graft function and no infectious complications after transplant.
